These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17631933)

  • 41. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.
    Harper MS; Guo K; Gibbert K; Lee EJ; Dillon SM; Barrett BS; McCarter MD; Hasenkrug KJ; Dittmer U; Wilson CC; Santiago ML
    PLoS Pathog; 2015; 11(11):e1005254. PubMed ID: 26529416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
    Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
    J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.
    Nakaya Y; Stavrou S; Blouch K; Tattersall P; Ross SR
    J Virol; 2016 Sep; 90(17):8005-12. PubMed ID: 27356895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
    Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
    Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages.
    Souza TM; Rodrigues DQ; Passaes CP; Barreto-de-Souza V; Aguiar RS; Temerozo JR; Morgado MG; Fontes CF; Araujo EG; Bou-Habib DC
    Blood; 2011 Mar; 117(10):2944-52. PubMed ID: 21217078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
    Chiu YL; Greene WC
    Trends Immunol; 2006 Jun; 27(6):291-7. PubMed ID: 16678488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.
    Monteleone K; Di Maio P; Cacciotti G; Falasca F; Fraulo M; Falciano M; Mezzaroma I; D'Ettorre G; Turriziani O; Scagnolari C
    Med Microbiol Immunol; 2014 Jun; 203(3):207-16. PubMed ID: 24553842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.
    Bogerd HP; Doehle BP; Wiegand HL; Cullen BR
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3770-4. PubMed ID: 14999100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular cloning and characterization of APOBEC3 family in tree shrew.
    Luo MT; Fan Y; Mu D; Yao YG; Zheng YT
    Gene; 2018 Mar; 646():143-152. PubMed ID: 29292195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFN-
    Tasker C; Subbian S; Gao P; Couret J; Levine C; Ghanny S; Soteropoulos P; Zhao X; Landau N; Lu W; Chang TL
    JCI Insight; 2016 Dec; 1(20):e88255. PubMed ID: 27942584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APOBEC4 Enhances the Replication of HIV-1.
    Marino D; Perković M; Hain A; Jaguva Vasudevan AA; Hofmann H; Hanschmann KM; Mühlebach MD; Schumann GG; König R; Cichutek K; Häussinger D; Münk C
    PLoS One; 2016; 11(6):e0155422. PubMed ID: 27249646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons.
    Cobos Jiménez V; Booiman T; de Taeye SW; van Dort KA; Rits MA; Hamann J; Kootstra NA
    Sci Rep; 2012; 2():763. PubMed ID: 23094138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heroin use is associated with lower levels of restriction factors and type I interferon expression and facilitates HIV-1 replication.
    Zhu JW; Liu FL; Mu D; Deng DY; Zheng YT
    Microbes Infect; 2017; 19(4-5):288-294. PubMed ID: 28104465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells.
    Pion M; Stalder R; Correa R; Mangeat B; Towers GJ; Piguet V
    J Virol; 2007 Nov; 81(21):12086-90. PubMed ID: 17728230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apobec 3F and apobec 3G have no inhibition and hypermutation effect on the human influenza A virus.
    Wang GF; Lin SY; Zhang H; Gao YL; Li WZ; Xin G; Li KS
    Acta Virol; 2008; 52(3):193-4. PubMed ID: 18999897
    [No Abstract]   [Full Text] [Related]  

  • 58. Damage control: how HIV survives the editor APOBEC3G.
    Croxford JL; Gasser S
    Nat Immunol; 2011 Sep; 12(10):925-7. PubMed ID: 21934670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle.
    Colomer-Lluch M; Gollahon LS; Serra-Moreno R
    Curr HIV Res; 2016; 14(3):175-82. PubMed ID: 26957194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CCR6 ligands inhibit HIV by inducing APOBEC3G.
    Lafferty MK; Sun L; DeMasi L; Lu W; Garzino-Demo A
    Blood; 2010 Feb; 115(8):1564-71. PubMed ID: 20023216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.